Rubric Capital Management (New York)’s Tarsus Pharmaceuticals TARS Stock Holding History

Rubric Capital Management (New York)’s Portfolio TARS Stock Details TARS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$2.78M	Sell
2022 Q4	$4.17M	Hold
2022 Q3	$4.88M	Buy
2022 Q2	$2.96M	Buy